Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Pushing Hepatitis C Pipeline, But Is It Fast Enough?
Seeking Alpha
Wed, 04/29/15 - 09:57 am
Tags:
AbbVie, hepatitis C, Viekira Pak, Japan, Europe
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Tags:
Gilead Sciences, Harvoni, hepatitis C, AbbVie, Bristol-Myers Squibb, Merck, Achillion
Roche, Amgen, Novo top the ranks in biologics sales, with AbbVie, Sanofi close behind
Fierce Pharma
Mon, 04/27/15 - 09:12 pm
Tags:
Roche, Amgen, Novo Nordisk, AbbVie, Sanofi
FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C
Marketwatch
Fri, 04/24/15 - 10:55 am
Tags:
FDA, AbbVie, OBV/PTV/r, Chronic Hepatitis C
Stellar Humira sales underscore AbbVie's need for replacement meds
Fierce Pharma
Thu, 04/23/15 - 04:58 pm
Tags:
AbbVie, Humira, earnings
AbbVie Profit Tops Estimates as Arthritis Drug Sales Rise
Bloomberg
Thu, 04/23/15 - 09:59 am
Tags:
AbbVie, earnings
AbbVie Earnings: What to Watch
WSJ Online
Wed, 04/22/15 - 08:54 am
Tags:
AbbVie, earnings
3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings
24/7 Wall St
Mon, 04/20/15 - 11:00 am
Tags:
earnings, Eli Lilly, Bristol-Myers Squibb, AbbVie
AbbVie moves closer to Japan's crowded hep C field with priority review nod
Fierce Pharma
Fri, 04/17/15 - 10:33 am
Tags:
AbbVie, Japan, hepatitis C, Viekira Pak
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
Tags:
AbbVie, AstraZeneca, Biomarin, Bristol-Myers Squibb, Celgene, Gilead Sciences, GSK, Hospira, Jazz Pharmaceuticals, Merck, Seattle Genetics, Shire
Could a restructuring help protect AbbVie when revenue troubles hit?
Fierce Pharma
Thu, 04/16/15 - 09:53 am
Tags:
AbbVie, restructuring
AbbVie: The Old & the New
Barron's
Wed, 04/15/15 - 08:55 am
Tags:
AbbVie, Galapagos, Humira
Five companies that may be looking to buy Ariad Pharmaceuticals
Bizjournals.com
Wed, 04/15/15 - 08:44 am
Tags:
Ariad Pharmaceuticals, M&A, Roche, Celgene, AbbVie, Gilead Sciences, Pfizer
Gilead: Little Hep C Competition, But What About Pricing?
Barron's
Fri, 04/10/15 - 03:50 pm
Tags:
Gilead Sciences, Merck, AbbVie, hepatitis C
Latest Merck, AbbVie Data Not A Threat To Gilead: Citi
Barron's
Wed, 04/8/15 - 12:05 pm
Tags:
Merck, AbbVie, hepatitis C, Gilead Sciences, grazoprevir/elbasvir, Harvoni
Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?
Motley Fool
Wed, 04/8/15 - 10:46 am
Tags:
AbbVie, Acadia, Parkinson's Disease, Nuplazid
10 Largest Companies by Market Cap in Pharmaceuticals
Motley Fool
Mon, 04/6/15 - 05:37 pm
Tags:
JNJ, Novartis, Pfizer, Merck, Sanofi, GSK, Bristol-Myers Squibb, AbbVie, AstraZeneca, Eli Lilly
Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says
Fierce Pharma
Mon, 04/6/15 - 11:46 am
Tags:
JNJ, M&A, Pharmacyclics, AbbVie, Alex Gorsky
What's Next For The Thousands Of Angry Men Suing Over Testosterone?
Forbes
Mon, 04/6/15 - 11:13 am
Tags:
testosterone, AbbVie, Endo Health Solutions
Is AbbVie Inc. Stock About to Crash?
Motley Fool
Thu, 04/2/15 - 10:03 am
Tags:
AbbVie, Pharmacyclics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.